Company Filing History:
3 out of 66 
1 out of 14 
1 out of 23 
Years Active: 2022-2025
Title: The Innovative Contributions of Anne Schlegel
Introduction
Anne Schlegel, an accomplished inventor hailing from Düsseldorf, Germany, has made significant strides in the field of biotechnology. With a total of two patents under her belt, Schlegel has been instrumental in developing innovative formulations for RNA delivery, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Schlegel's latest patents revolve around formulations for the administration of RNA. These inventions focus on polyplex formulations designed to deliver RNA to target organs or cells following parenteral administration, particularly through intramuscular injections. The inventions specifically address the use of self-replicating RNA and involve the creation of polyplex particles derived from single-stranded RNA and polyalkyleneimine. Moreover, these formulations not only enable the encoding of pharmaceutically active proteins but also pave the way for the development of pharmaceutical products intended for parenteral application in humans and animals. The manufacturing processes for these products may also include steps such as sterile filtration, freezing, and dehydration, highlighting the thorough approach taken in her innovations.
Career Highlights
Anne Schlegel has worked with notable organizations such as BioNTech SE and the Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz. Her background in these leading research institutions underscores her significant contributions to the development of novel medical therapies, primarily focusing on RNA technology.
Collaborations
Throughout her career, Schlegel has collaborated with esteemed colleagues, including Ugur Sahin and Heinrich Haas. These partnerships have enriched her research endeavors, allowing for a multidisciplinary approach to complex scientific challenges.
Conclusion
In summary, Anne Schlegel's innovative work in RNA formulations not only reflects her personal dedication to the advancement of medical science but also contributes to the broader field of biotechnology. Her patents demonstrate the potential for groundbreaking applications, paving the way for future developments in RNA therapy and pharmaceutical formulations.